Article: article from journal or magazin.
Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia.
The New England Journal of Medicine
Genetic deficiency of ectodysplasin A (EDA) causes X-linked hypohidrotic ectodermal dysplasia (XLHED), in which the development of sweat glands is irreversibly impaired, an condition that can lead to life-threatening hyperthermia. We observed normal development of mouse fetuses with Eda mutations after they had been exposed in utero to a recombinant protein that includes the receptor-binding domain of EDA. We administered this protein intraamniotically to two affected human twins at gestational weeks 26 and 31 and to a single affected human fetus at gestational week 26; the infants, born in week 33 (twins) and week 39 (singleton), were able to sweat normally, and XLHED-related illness had not developed by 14 to 22 months of age. (Funded by Edimer Pharmaceuticals and others.).
Adult, Amniotic Fluid, Antigens, CD/therapeutic use, Ectodermal Dysplasia 1, Anhidrotic/diagnostic imaging, Ectodermal Dysplasia 1, Anhidrotic/genetics, Ectodermal Dysplasia 1, Anhidrotic/therapy, Ectodysplasins/deficiency, Ectodysplasins/genetics, Ectodysplasins/therapeutic use, Female, Fetal Therapies/methods, Genetic Therapy/methods, Humans, Injections, Male, Mutation, Pregnancy, Prenatal Diagnosis, Radiography, Receptors, Fc/therapeutic use, Recombinant Proteins/therapeutic use, Sweat Glands/abnormalities, Sweat Glands/diagnostic imaging, Tooth Germ/diagnostic imaging
Web of science
Last modification date